Your Brain May Be Working Against You When It Comes to Sex.
Hypoactive sexual desire disorder (HSDD) is the most common form of sexual dysfunction in women.1 There hasn’t been a treatment until now.
Addyi is the first and only FDA-approved treatment for acquired, generalized hypoactive (low) sexual desire disorder—HSDD—in women who have not gone through menopause. Symptoms of HSDD include low libido and associated distress.
To understand what HSDD is, it's also important to understand what HSDD is not.
- You were satisfied in the past with your desire for sex
- Your desire for sex has decreased
- Your decreased desire for sex has persisted for 6 months or more
- Your decreased desire for sex is bothering you
Healthy (Not HSDD)
- HSDD is not a lack of desire for sex due to relationship issues
- HSDD is not a lack of desire for sex caused by a medical or mental health issue
- HSDD is not a lack of desire for sex caused by a medication that you are taking
Addyi is a prescription non-hormonal pill taken every day at bedtime. It is the only FDA approved treatment for Hypoactive Sexual Desire Disorder (HSDD). Addyi is believed to work on the part of the brain involved in sexual motivation and response though it’s exact mechanism of action is not fully understood.6 In clinical studies with ADDYI, some women experienced improvement in one or more of their HSDD symptoms,7,8,9 including:
- INCREASED sexual desire
- INCREASED number of times in a month that a woman had satisfying sexual intercourse or engaged in other satisfying sexual activity, such as oral sex, masturbation, or genital stimulation by a partner
- DECREASED distress associated with low sexual desire
Not all women will experience similar improvement in their HSDD. Speak with your doctor about the benefits and the risks associated with taking Addyi. See IMPORTANT SAFETY INFORMATION below. Addyi is not FEMALE Viagra.
Desire is in the brain.
Is Addyi right for you?
Speak with a US licensed doctor* from the privacy of your own home.
Free home delivery of Addyi for
as little as $25/month**
Connect with a doctor
By clicking here you will leave addyi.com and go to the telemedicine provider
- *The $49 doctor consult and free home delivery are through third party providers.
- **Should your insurer not cover Addyi or you’re uninsured, you’ll never pay more than $99/month.
Telemedicine is a significant and rapidly growing component of health care in the United States that allows health care professionals to evaluate, diagnose and treat patients at a distance using telecommunications (ie phone/computer) technology. Every doctor you interact with is licensed to treat patients in your state and complies with all governing medical laws in the US.
If your commercial prescription insurance covers Addyi, you will pay no more than $25/month for your prescription (less than $1/day).
If your commercial prescription insurance does not cover Addyi, or if you pay cash, you will pay no more than $99/month out of pocket for your prescription (less than $4 per day) using the home delivery service.
Setting up a telemedicine consultation is simple and secure. All from the comfort of your couch! Click GET ADDYI NOW and you will be connected to an independent network of U.S. licensed doctors who are specially trained and certified on Addyi. There, you will be guided through three simple steps:
- You will answer some introductory questions to see if you are eligible for a confidential online doctor visit.
- If eligible, you will be connected with a Care Guide who will prepare you for your confidential online doctor visit. Or, you may choose to schedule an online visit at a later time that is convenient for you.
- You will complete a confidential doctor visit with a U.S. licensed doctor over the phone (telemedicine) to determine if Addyi may be right for you. Only a healthcare provider can determine if Addyi is right for you.
The GET ADDYI NOW online service and its participating healthcare professionals are independent and not employees or contractors of Sprout Pharmaceuticals.
Yes, all participating doctors in the GET ADDYI NOW online service are licensed, board certified and located in the United States. Every doctor you interact with through this service is licensed to treat patients in your state and complies with all governing medical laws in the US.
This consult fee is a one-time $49 payment for your telemedicine consultation, which is similar to the co-pay you would incur for an in-person doctor visit. You may check with your insurance provider to determine if the consult fee can be reimbursed by your specific plan. The telemedicine consult fee is an eligible expense for reimbursement under Health Savings Accounts (HSA) or Health Care Flexible Spending Accounts (FSA).
Choosing the telemedicine consultation is simply an option that may make the process of getting started on Addyi more convenient for you. You always have the option to see a healthcare provider of your choice in person as well.
Addyi may or may not be covered by your commercial prescription insurance provider. If you choose the free home delivery option, the pharmacy will advise you whether or not Addyi is covered by your plan. If your commercial insurance covers Addyi, the cost is as little as $25/month. If your commercial insurance does not cover Addyi, or if you pay cash, you will pay no more than $99/month out of pocket for your prescription (less than $4 per day). Should your insurer not cover Addyi, free home delivery is your lowest cost option. No special coupon is required.
What is the home delivery pharmacy option provided through the GET ADDYI NOW online service?
Once you select free home delivery, a speciality pharmacy will discreetly deliver your Addyi prescription straight to your doorstep.
If you already have an Addyi prescription at a local pharmacy, you can transfer your prescription by calling 877-809-3141. Be prepared to provide some basic information. A speciality pharmacy will verify your prescription, check your insurance coverage and provide free home delivery.
I already use Addyi, can I transfer my prescription to the home delivery pharmacy?
Yes. Call 877-809-3141. Be prepared to provide some basic information. A speciality pharmacy will verify your prescription, check your insurance coverage and complete the prescription transfer for you.
My local doctor wrote a prescription for Addyi. How can I take advantage of the free home delivery pharmacy option?
To get started, call 877-809-3141. Be prepared to provide some basic information. A speciality pharmacy will verify your prescription, check your insurance coverage and and provide free home delivery.
References: 1. Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970-8. 2. Holstege G, Weijmar- Schultz W. How combined serotonin-1A receptor agonist and 2A- receptor antagonist can heal hypoactive sexual desire disorder (HSDD). Poster presented at Neuroscience 2014 the Society for Neuroscience 2014 Annual Meeting (SfN); November 15-19, 2014; Washington, DC. 3. Woodard TL, Nowak NT, Balon R, Diamond MP. Brain activation patterns in women with acquired hypoactive sexual desire disorder and women with normal sexual function: A cross-sectional pilot study. Fertil Steril. 2013; 100(4): 1068-1076. 4. Arnow BA, Millheiser L, Garrett A, et al. Women with hypoactive sexual desire disorder compared to normal females: A functional magnetic resonance imaging study. Neuroscience. 2009; 158:484-502. 5. Bianchi‐Demicheli F, Cojan Y, Waber L, Recordon N, Vuilleumier P, and Ortigue S. Neural bases of hypoactive sexual desire disorder in women: An event‐related fMRI study. J Sex Med 2011;8:2546–2559. 5. Bianchi‐Demicheli F, Cojan Y, Waber L, Recordon N, Vuilleumier P, and Ortigue S. Neural bases of hypoactive sexual desire disorder in women: An event‐related fMRI study. J Sex Med. 2011;8:2546–2559. 6. Stephen M. Stahl Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder. CNS Spectrums, Available on CJO 2015 doi:10.1017/S1092852914000832. 7. DeRogatis LR, Komer L, Katz M, et al; VIOLET trial investigators. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study. J Sex Med. 2012;9(4):1074-1085. 8. Thorp J, Simon J, Dattani D, et al; DAISY trial investigators. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med. 2012;9(3):793-804. 9. Katz M, DeRogatis LR, Ackerman R, et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med. 2013;10(7):1807-1815.